Paul Sauer, SVP Process Development, Manufacturing at Vaxcyte, Inc. (PCVX), sold 10,614 shares at $25.20 ($267K) on 2021-09-22, disclosed to the SEC on 2021-09-24.
Open-market sale of $267k PCVX by SVP Process Development, Manufacturing. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.20 | 5,307 | $134K | 50.0% |
| 2 | $25.20 | 5,307 | $134K | 50.0% |
| Total | $25.20 avg | 10,614 | $267K | 100% |
| Filing → |
| PCVX | SELL | 2022-07-22 | $75K | — | Filing → |
| PCVX | SELL | 2022-05-25 | $79K | — | Filing → |
| PCVX | SELL | 2022-04-26 | $75K | — | Filing → |